CAMPHOR, EUCALYPTUS OIL, MENTHOL

CAMPHOR, EUCALYPTUS OIL, MENTHOL was reported 235 times

CAMPHOR, EUCALYPTUS OIL, MENTHOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BEZOLD ABSCESS 1 0.1429
1 PYLOROSPASM 1 0.0455
2 ARTERIAL STENOSIS LIMB 1 0.0196
3 ELEPHANTIASIS 1 0.0149
4 ANAESTHETIC COMPLICATION CARDIAC 1 0.0145
5 LUDWIG ANGINA 1 0.0069
6 SOCIOECONOMIC PRECARITY 1 0.0058
7 PROCEDURAL HYPERTENSION 1 0.0053
8 DEAFNESS PERMANENT 1 0.0051
9 GLOMERULONEPHRITIS ACUTE 1 0.0049
10 PERIPHERAL NERVE OPERATION 1 0.0046
11 VAGINAL MYCOSIS 1 0.0043
12 INFESTATION 1 0.0039
13 PANCREATIC INJURY 1 0.0033
14 CAUSTIC INJURY 1 0.0032
15 OESOPHAGEAL ACHALASIA 2 0.0031
16 EAR OPERATION 1 0.0027
17 MESOTHELIOMA MALIGNANT 1 0.0027
18 VERTEBRAL OSTEOPHYTE 1 0.0023
19 VULVOVAGINAL RASH 1 0.0023
20 BLEPHARAL PIGMENTATION 1 0.0020
21 FAECAL VOLUME INCREASED 1 0.0019
22 SCAPULA FRACTURE 1 0.0019
23 RETROPERITONEAL LYMPHADENOPATHY 1 0.0019
24 INSTILLATION SITE REACTION 2 0.0018
25 PORTAL HYPERTENSIVE GASTROPATHY 1 0.0018
26 ANTERIOR CHAMBER INFLAMMATION 1 0.0017
27 SACRAL PAIN 1 0.0016
28 MITRAL VALVE CALCIFICATION 1 0.0016
29 HYPOTRICHOSIS 1 0.0016
30 INJECTION SITE EXFOLIATION 1 0.0015
31 BORDERLINE PERSONALITY DISORDER 1 0.0014
32 BACTERIAL DISEASE CARRIER 1 0.0014
33 WITHDRAWAL BLEED 1 0.0014
34 ASPIRATION PLEURAL CAVITY 1 0.0013
35 ENDOCARDITIS BACTERIAL 1 0.0013
36 OCULAR VASCULAR DISORDER 1 0.0012
37 ADRENAL MASS 1 0.0012
38 BILIARY DYSKINESIA 2 0.0012
39 ENDOCRINE OPHTHALMOPATHY 1 0.0012
40 ABDOMINAL LYMPHADENOPATHY 1 0.0012
41 OESOPHAGEAL OBSTRUCTION 1 0.0012
42 FOLLICULAR LYMPHOMA 1 0.0011
43 ABDOMINAL SEPSIS 1 0.0011
44 MUSCLE CRAMP 2 0.0011
45 LIGAMENT DISORDER 1 0.0011
46 LIPOATROPHY 1 0.0011
47 DUODENAL PERFORATION 1 0.0010
48 SKIN OEDEMA 1 0.0010
49 ONYCHALGIA 1 0.0010
50 EYE COLOUR CHANGE 1 0.0010
51 RENAL MASS 2 0.0010
52 NASAL INFLAMMATION 1 0.0009
53 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
54 NAIL GROWTH ABNORMAL 1 0.0009
55 DILATATION ATRIAL 1 0.0009
56 INFREQUENT BOWEL MOVEMENTS 2 0.0008
57 AUDITORY DISORDER 1 0.0007
58 SEBORRHOEIC KERATOSIS 1 0.0007
59 REBOUND ACID HYPERSECRETION 2 0.0007
60 NEPHROGENIC ANAEMIA 3 0.0006
61 GASTROINTESTINAL STOMA COMPLICATION 1 0.0006
62 TINEA PEDIS 1 0.0006
63 OROPHARYNGEAL BLISTERING 1 0.0006
64 EROSIVE OESOPHAGITIS 1 0.0006
65 CAROTID ARTERY STENOSIS 2 0.0006
66 DRUG SCREEN NEGATIVE 1 0.0006
67 INTRA-ABDOMINAL FLUID COLLECTION 1 0.0006
68 MOTION SICKNESS 1 0.0005
69 VOCAL CORD DISORDER 1 0.0005
70 PHYSICAL ASSAULT 1 0.0005
71 BODY HEIGHT DECREASED 5 0.0005
72 INFECTION SUSCEPTIBILITY INCREASED 1 0.0005
73 DANDRUFF 1 0.0005
74 GASTROINTESTINAL ULCER 1 0.0005
75 CYTOMEGALOVIRUS COLITIS 1 0.0004
76 BREAKTHROUGH PAIN 1 0.0004
77 PUSTULE 1 0.0004
78 INSTILLATION SITE PAIN 1 0.0004
79 HYPERPARATHYROIDISM SECONDARY 1 0.0004
80 VENTRICULAR HYPERTROPHY 1 0.0004
81 RETINAL ARTERY OCCLUSION 1 0.0004
82 BLOOD POTASSIUM ABNORMAL 1 0.0004
83 TRICHORRHEXIS 1 0.0004
84 JOINT LOCK 1 0.0004
85 IMPAIRED DRIVING ABILITY 4 0.0004
86 PHARYNGEAL DISORDER 1 0.0003
87 DYSCHEZIA 1 0.0003
88 MEDICAL DEVICE DISCOMFORT 1 0.0003
89 MASTICATION DISORDER 1 0.0003
90 EYELIDS PRURITUS 1 0.0003
91 PRE-EXISTING CONDITION IMPROVED 2 0.0003
92 CARDIAC FLUTTER 2 0.0003
93 DEAFNESS NEUROSENSORY 1 0.0003
94 WOUND DEHISCENCE 1 0.0003
95 ULCER HAEMORRHAGE 2 0.0003
96 HANGOVER 1 0.0003
97 APPLICATION SITE REACTION 2 0.0003
98 THERMAL BURN 2 0.0003
99 SKIN WEEPING 1 0.0003
100 FREEZING PHENOMENON 1 0.0003
101 ORAL INFECTION 1 0.0003
102 WOUND SECRETION 1 0.0003
103 PROSTATOMEGALY 1 0.0003
104 AZOTAEMIA 1 0.0003
105 SPINAL COMPRESSION FRACTURE 2 0.0002
106 SOCIAL PROBLEM 1 0.0002
107 THYROID FUNCTION TEST ABNORMAL 1 0.0002
108 SLEEP TERROR 1 0.0002
109 TONGUE DISCOMFORT 1 0.0002
110 PURULENT DISCHARGE 1 0.0002
111 HORDEOLUM 1 0.0002
112 CHAPPED LIPS 1 0.0002
113 ONYCHOMYCOSIS 1 0.0002
114 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
115 EXOSTOSIS 2 0.0002
116 ARTHRITIS INFECTIVE 1 0.0002
117 GASTRITIS EROSIVE 1 0.0002
118 BLOOD PROLACTIN INCREASED 1 0.0002
119 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
120 VULVOVAGINAL PAIN 1 0.0002
121 APPLICATION SITE BURN 1 0.0002
122 APPLICATION SITE SWELLING 1 0.0002
123 PROTEIN URINE PRESENT 1 0.0002
124 HEPATIC ENZYME ABNORMAL 1 0.0002
125 VEIN DISORDER 1 0.0002
126 CORONARY ARTERY STENOSIS 1 0.0002
127 VULVOVAGINAL PRURITUS 1 0.0002
128 SKIN NECROSIS 1 0.0002
129 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
130 OVERWEIGHT 1 0.0002
131 ERYTHEMA OF EYELID 1 0.0002
132 BIPOLAR DISORDER 2 0.0002
133 ASTHENOPIA 1 0.0002
134 STREPTOCOCCAL INFECTION 1 0.0002
135 NECROSIS 1 0.0002
136 INTRACRANIAL PRESSURE INCREASED 1 0.0002
137 CHOLECYSTECTOMY 2 0.0002
138 HYPERVENTILATION 1 0.0002
139 METABOLIC DISORDER 1 0.0002
140 PRODUCT LABEL CONFUSION 1 0.0002
141 SINUS HEADACHE 1 0.0002
142 PROTHROMBIN TIME PROLONGED 1 0.0002
143 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
144 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
145 INJECTION SITE VESICLES 1 0.0002
146 FOREIGN BODY SENSATION IN EYES 1 0.0002
147 POOR QUALITY DRUG ADMINISTERED 1 0.0002
148 TENDON DISORDER 1 0.0002
149 POLYP 1 0.0002
150 WALKING AID USER 1 0.0002
151 PRODUCT FORMULATION ISSUE 1 0.0002
152 SKIN MASS 1 0.0001
153 CHOLECYSTITIS CHRONIC 1 0.0001
154 IMPAIRED GASTRIC EMPTYING 2 0.0001
155 BLOOD TESTOSTERONE DECREASED 1 0.0001
156 INFARCTION 1 0.0001
157 CHRONIC KIDNEY DISEASE 11 0.0001
158 HAIR GROWTH ABNORMAL 1 0.0001
159 HUNGER 2 0.0001
160 EXTRASYSTOLES 1 0.0001
161 DEFAECATION URGENCY 1 0.0001
162 INCORRECT DRUG ADMINISTRATION DURATION 4 0.0001
163 PRODUCT SUPPLY ISSUE 1 0.0001
164 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
165 POOR QUALITY SLEEP 3 0.0001
166 SKIN HAEMORRHAGE 2 0.0001
167 APPLICATION SITE PRURITUS 3 0.0001
168 HAIR DISORDER 1 0.0001
169 EYE PRURITUS 4 0.0001
170 PARANOIA 2 0.0001
171 NAIL DISORDER 1 0.0001
172 RESPIRATORY RATE INCREASED 1 0.0001
173 END STAGE RENAL DISEASE 2 0.0001
174 PNEUMONIA BACTERIAL 1 0.0001
175 BLOOD CHOLESTEROL INCREASED 5 0.0001
176 DIARRHOEA HAEMORRHAGIC 1 0.0001
177 FLANK PAIN 1 0.0001
178 HEPATIC CIRRHOSIS 2 0.0001
179 PHOTOPHOBIA 2 0.0001
180 ARTERIOSCLEROSIS 1 0.0001
181 EYE IRRITATION 6 0.0001
182 ACUTE RESPIRATORY FAILURE 2 0.0001
183 DIZZINESS POSTURAL 1 0.0001
184 PHARYNGEAL SWELLING 1 0.0001
185 LIGAMENT SPRAIN 1 0.0001
186 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
187 SPINAL FRACTURE 2 0.0001
188 SKELETAL INJURY 1 0.0001
189 HYPERBILIRUBINAEMIA 1 0.0001
190 EYE DISCHARGE 1 0.0001
191 IMPAIRED WORK ABILITY 2 0.0001
192 DECREASED ACTIVITY 1 0.0001
193 BLOOD GLUCOSE FLUCTUATION 1 0.0001
194 GASTROINTESTINAL PAIN 1 0.0001
195 FOOT DEFORMITY 1 0.0001
196 SNEEZING 2 0.0001
197 EYE INFECTION 1 0.0001
198 HEART RATE IRREGULAR 2 0.0001
199 MITRAL VALVE INCOMPETENCE 1 0.0001
200 NEOPLASM 1 0.0001
201 MADAROSIS 1 0.0001
202 EYELID OEDEMA 1 0.0001
203 VASCULITIS 1 0.0001
204 MENTAL IMPAIRMENT 2 0.0001
205 BURSITIS 1 0.0001
206 SCHIZOPHRENIA 1 0.0001
207 INJECTION SITE EXTRAVASATION 1 0.0001
208 CYST 1 0.0001
209 ILEUS 1 0.0001
210 SECRETION DISCHARGE 1 0.0001
211 PRODUCT USE ISSUE 15 0.0001
212 INTESTINAL OBSTRUCTION 3 0.0001
213 INJECTION SITE IRRITATION 1 0.0001
214 THERAPY CESSATION 4 0.0001
215 HIATUS HERNIA 1 0.0001
216 PHARMACEUTICAL PRODUCT COMPLAINT 2 0.0001
217 APPLICATION SITE ERYTHEMA 2 0.0001
218 ORAL CANDIDIASIS 1 0.0001
219 RENAL FAILURE 10 0.0001
220 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
221 FEAR 2 0.0001
222 ORAL DISCOMFORT 1 0.0001
223 DIALYSIS 1 0.0001
224 IMPAIRED QUALITY OF LIFE 1 0.0001
225 PARAESTHESIA ORAL 1 0.0001
226 MYELODYSPLASTIC SYNDROME 1 0.0001
227 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
228 URINARY INCONTINENCE 2 0.0001
229 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
230 THROAT IRRITATION 3 0.0001
231 HYPOAESTHESIA ORAL 1 0.0001
232 LACRIMATION INCREASED 2 0.0001
233 CORONARY ARTERY DISEASE 2 0.0001
234 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
235 DEVICE FAILURE 1 0.0001
236 ACUTE KIDNEY INJURY 10 0.0001
237 HIP ARTHROPLASTY 1 0.0001
238 MUSCULOSKELETAL CHEST PAIN 1 0.0001
239 DELUSION 1 0.0001
240 EJECTION FRACTION DECREASED 1 0.0001
241 MOVEMENT DISORDER 2 0.0001
242 BLOOD POTASSIUM INCREASED 1 0.0001
243 IMPAIRED HEALING 2 0.0001
244 MANIA 1 0.0001
245 EXPIRED PRODUCT ADMINISTERED 2 0.0001
246 SKIN DISORDER 2 0.0001
247 HEMIPARESIS 1 0.0001
248 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
249 MULTI-ORGAN FAILURE 1 0.0001
250 DEVICE DEFECTIVE 1 0.0001
251 INTENTIONAL PRODUCT MISUSE 5 0.0001
252 HEART RATE DECREASED 2 0.0001
253 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
254 GALLBLADDER DISORDER 1 0.0001
255 GOUT 1 0.0001
256 TOOTHACHE 1 0.0001
257 DRUG EFFECT INCOMPLETE 2 0.0001
258 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
259 DYSPNOEA EXERTIONAL 2 0.0001
260 FLATULENCE 3 0.0001
261 COLITIS 2 0.0001
262 BLOOD URINE PRESENT 1 0.0001
263 SLEEP APNOEA SYNDROME 1 0.0001
264 INCREASED APPETITE 1 0.0001
265 LETHARGY 3 0.0001
266 PULMONARY FIBROSIS 1 0.0001
267 POST PROCEDURAL COMPLICATION 1 0.0001
268 DRUG PRESCRIBING ERROR 1 0.0001
269 ERUCTATION 1 0.0001
270 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
271 SINUS DISORDER 1 0.0001
272 CONSTIPATION 11 0.0001
273 PRODUCT ADMINISTRATION ERROR 1 0.0000
274 FEEDING DISORDER 1 0.0000
275 OSTEOPOROSIS 2 0.0000
276 RIB FRACTURE 1 0.0000
277 PULMONARY HYPERTENSION 1 0.0000
278 DERMATITIS 1 0.0000
279 HALLUCINATION, VISUAL 1 0.0000
280 RENAL FAILURE ACUTE 2 0.0000
281 JOINT INJURY 1 0.0000
282 RECTAL HAEMORRHAGE 2 0.0000
283 SEPTIC SHOCK 2 0.0000
284 APPLICATION SITE PAIN 1 0.0000
285 STEVENS-JOHNSON SYNDROME 1 0.0000
286 GLOSSODYNIA 1 0.0000
287 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
288 TINNITUS 2 0.0000
289 MUSCLE TWITCHING 1 0.0000
290 PERICARDIAL EFFUSION 1 0.0000
291 COGNITIVE DISORDER 2 0.0000
292 INJURY 3 0.0000
293 SLEEP DISORDER 3 0.0000
294 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
295 DISEASE RECURRENCE 2 0.0000
296 BLOOD PRESSURE FLUCTUATION 1 0.0000
297 DIABETIC KETOACIDOSIS 1 0.0000
298 ENCEPHALOPATHY 1 0.0000
299 ABASIA 1 0.0000
300 DYSGEUSIA 3 0.0000
301 WEIGHT INCREASED 9 0.0000
302 PNEUMONIA ASPIRATION 1 0.0000
303 CELLULITIS 2 0.0000
304 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
305 DEPRESSION 9 0.0000
306 ABDOMINAL PAIN LOWER 1 0.0000
307 GASTRIC CANCER 1 0.0000
308 PRODUCT COMPLAINT 1 0.0000
309 HAEMATEMESIS 1 0.0000
310 ANXIETY 11 0.0000
311 HAEMATOMA 1 0.0000
312 NERVOUSNESS 2 0.0000
313 MUSCULOSKELETAL PAIN 2 0.0000
314 GASTRITIS 1 0.0000
315 HYPERSENSITIVITY 7 0.0000
316 EAR INFECTION 1 0.0000
317 BREAST CANCER FEMALE 1 0.0000
318 MENSTRUATION IRREGULAR 1 0.0000
319 JAUNDICE 1 0.0000
320 DRY MOUTH 3 0.0000
321 LIMB INJURY 1 0.0000
322 PALLOR 1 0.0000
323 INFLUENZA LIKE ILLNESS 3 0.0000
324 DRUG DOSE OMISSION 6 0.0000
325 RESPIRATORY DISTRESS 1 0.0000
326 ABNORMAL DREAMS 1 0.0000
327 PROCEDURAL PAIN 1 0.0000
328 NECK PAIN 2 0.0000
329 ABDOMINAL DISCOMFORT 6 0.0000
330 MUSCULAR WEAKNESS 4 0.0000
331 DYSSTASIA 1 0.0000
332 MUSCULOSKELETAL STIFFNESS 3 0.0000
333 ASCITES 1 0.0000
334 ABDOMINAL PAIN UPPER 7 0.0000
335 CATARACT 2 0.0000
336 RESPIRATORY DISORDER 1 0.0000
337 IRRITABILITY 2 0.0000
338 PLEURAL EFFUSION 2 0.0000
339 BLOOD PRESSURE INCREASED 5 0.0000
340 EMOTIONAL DISORDER 1 0.0000
341 GYNAECOMASTIA 1 0.0000
342 NERVOUS SYSTEM DISORDER 1 0.0000
343 HEAD INJURY 1 0.0000
344 HYPOTHYROIDISM 1 0.0000
345 HIP FRACTURE 1 0.0000
346 DYSPEPSIA 3 0.0000
347 EYE DISORDER 1 0.0000
348 HEART RATE INCREASED 3 0.0000
349 VISUAL ACUITY REDUCED 1 0.0000
350 FALL 10 0.0000
351 LIP SWELLING 1 0.0000
352 FUNGAL INFECTION 1 0.0000
353 GAIT INABILITY 1 0.0000
354 TYPE 2 DIABETES MELLITUS 1 0.0000
355 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
356 PRODUCT QUALITY ISSUE 4 0.0000
357 HEPATIC ENZYME INCREASED 2 0.0000
358 GASTRIC DISORDER 1 0.0000
359 VISION BLURRED 4 0.0000
360 ABDOMINAL DISTENSION 3 0.0000
361 WEIGHT DECREASED 8 0.0000
362 COUGH 8 0.0000
363 BURNING SENSATION 2 0.0000
364 HYPERKALAEMIA 1 0.0000
365 HYPERTENSION 6 0.0000
366 CRYING 1 0.0000
367 RESTLESSNESS 1 0.0000
368 MUSCLE SPASMS 5 0.0000
369 DYSURIA 1 0.0000
370 PAIN IN EXTREMITY 8 0.0000
371 INJECTION SITE MASS 1 0.0000
372 EYE SWELLING 1 0.0000
373 HEPATIC FUNCTION ABNORMAL 1 0.0000
374 INSOMNIA 7 0.0000
375 INJECTION SITE SWELLING 2 0.0000
376 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
377 BACK PAIN 6 0.0000
378 PALPITATIONS 3 0.0000
379 ARTHRITIS 2 0.0000
380 ABNORMAL BEHAVIOUR 1 0.0000
381 DISORIENTATION 1 0.0000
382 CARDIAC FAILURE 2 0.0000
383 CARDIAC FAILURE CONGESTIVE 2 0.0000
384 SOMNOLENCE 5 0.0000
385 DYSPNOEA 14 0.0000
386 EXTRA DOSE ADMINISTERED 1 0.0000
387 OEDEMA PERIPHERAL 3 0.0000
388 BLINDNESS 1 0.0000
389 NEUTROPHIL COUNT DECREASED 1 0.0000
390 INJECTION SITE ERYTHEMA 3 0.0000
391 DIZZINESS 12 0.0000
392 ARTHRALGIA 10 0.0000
393 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
394 CARDIO-RESPIRATORY ARREST 1 0.0000
395 ROAD TRAFFIC ACCIDENT 1 0.0000
396 LOSS OF CONSCIOUSNESS 3 0.0000
397 MENTAL DISORDER 1 0.0000
398 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
399 LIVER DISORDER 1 0.0000
400 DEHYDRATION 3 0.0000
401 ADVERSE DRUG REACTION 2 0.0000
402 SUICIDAL IDEATION 2 0.0000
403 NASOPHARYNGITIS 4 0.0000
404 HYPOKALAEMIA 1 0.0000
405 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
406 ABDOMINAL PAIN 5 0.0000
407 CARDIAC DISORDER 2 0.0000
408 SWELLING 2 0.0000
409 ARRHYTHMIA 1 0.0000
410 OCULAR HYPERAEMIA 1 0.0000
411 DYSPHAGIA 2 0.0000
412 PULMONARY EMBOLISM 2 0.0000
413 PRODUCTIVE COUGH 1 0.0000
414 MULTIPLE SCLEROSIS 1 0.0000
415 GAIT DISTURBANCE 4 0.0000
416 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
417 CONTUSION 2 0.0000
418 ATRIAL FIBRILLATION 2 0.0000
419 ALOPECIA 4 0.0000
420 DRY EYE 1 0.0000
421 SYNCOPE 2 0.0000
422 FLUID RETENTION 1 0.0000
423 CHEST DISCOMFORT 2 0.0000
424 ILLNESS 2 0.0000
425 FATIGUE 15 0.0000
426 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
427 HEADACHE 12 0.0000
428 OEDEMA 1 0.0000
429 PRURITUS 7 0.0000
430 TREMOR 3 0.0000
431 ARTHROPATHY 1 0.0000
432 URTICARIA 3 0.0000
433 PAIN 11 0.0000
434 PANCYTOPENIA 1 0.0000
435 BLISTER 1 0.0000
436 HYPONATRAEMIA 1 0.0000
437 EYE PAIN 1 0.0000
438 CEREBROVASCULAR ACCIDENT 3 0.0000
439 INCORRECT DOSE ADMINISTERED 4 0.0000
440 PRODUCT SUBSTITUTION ISSUE 1 0.0000
441 MYOCARDIAL INFARCTION 3 0.0000
442 DYSPHONIA 1 0.0000
443 BONE PAIN 1 0.0000
444 NASAL CONGESTION 1 0.0000
445 VOMITING 8 0.0000
446 EMOTIONAL DISTRESS 2 0.0000
447 THERAPEUTIC RESPONSE DECREASED 1 0.0000
448 DISCOMFORT 1 0.0000
449 CHEST PAIN 3 0.0000
450 ASTHENIA 6 0.0000
451 PNEUMONIA 5 0.0000
452 DEEP VEIN THROMBOSIS 1 0.0000
453 BLOOD PRESSURE DECREASED 1 0.0000
454 DRY SKIN 2 0.0000
455 NEOPLASM MALIGNANT 1 0.0000
456 HYPOTENSION 3 0.0000
457 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
458 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
459 OVERDOSE 3 0.0000
460 INFECTION 2 0.0000
461 RASH 6 0.0000
462 UNDERDOSE 1 0.0000
463 DRUG INEFFECTIVE 18 0.0000
464 BRONCHITIS 1 0.0000
465 HYPOAESTHESIA 2 0.0000
466 HALLUCINATION 1 0.0000
467 HOT FLUSH 1 0.0000
468 UNEVALUABLE EVENT 1 0.0000
469 DIABETES MELLITUS 1 0.0000
470 DECREASED APPETITE 3 0.0000
471 PARAESTHESIA 2 0.0000
472 NAUSEA 10 0.0000
473 INJECTION SITE BRUISING 1 0.0000
474 INJECTION SITE HAEMORRHAGE 1 0.0000
475 FEELING ABNORMAL 3 0.0000
476 SKIN EXFOLIATION 1 0.0000
477 MYALGIA 2 0.0000
478 URINARY TRACT INFECTION 2 0.0000
479 PRODUCT STORAGE ERROR 1 0.0000
480 MALAISE 5 0.0000
481 TACHYCARDIA 1 0.0000
482 ADVERSE EVENT 1 0.0000
483 OROPHARYNGEAL PAIN 1 0.0000
484 BLOOD GLUCOSE INCREASED 2 0.0000
485 MIGRAINE 1 0.0000
486 INJECTION SITE PAIN 3 0.0000
487 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
488 ERYTHEMA 2 0.0000
489 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
490 HAEMORRHAGE 1 0.0000
491 PLATELET COUNT DECREASED 1 0.0000
492 DIARRHOEA 6 0.0000
493 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
494 INFLUENZA 1 0.0000
495 SEPSIS 1 0.0000
496 RHEUMATOID ARTHRITIS 1 0.0000
497 SEIZURE 1 0.0000
498 CHILLS 1 0.0000
499 DISEASE PROGRESSION 1 0.0000
500 JOINT SWELLING 1 0.0000
501 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
502 VISUAL IMPAIRMENT 1 0.0000
503 OFF LABEL USE 7 0.0000
504 HYPERHIDROSIS 1 0.0000
505 PRODUCT DOSE OMISSION ISSUE 2 0.0000
506 CONDITION AGGRAVATED 2 0.0000
507 PERIPHERAL SWELLING 1 0.0000
508 DRUG INTERACTION 1 0.0000
509 DRUG DEPENDENCE 1 0.0000
510 CONFUSIONAL STATE 1 0.0000
511 PYREXIA 2 0.0000
512 COVID-19 1 0.0000
513 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
514 NO ADVERSE EVENT 1 0.0000
515 ANAEMIA 1 0.0000